-+ 0.00%
-+ 0.00%
-+ 0.00%

Mesoblast Study Finds Remestemcel-L Outperforms Ruxolitinib in Treating Steroid-Refractory aGvHD

路透·12/11/2025 23:22:46

登录查看新闻详情